TechIsomorphic Labs raises $5B to advance drug candidates to clinical trials
Isomorphic Labs, an AI drug-discovery platform spun out of Google’s DeepMind in 2021, has raised $5 billion in a Series C round as it seeks to move drug candidates into clinical trials.
Isomorphic Labs raises $5B to advance drug candidates to clinical trials
Tech